Commentary on the draft revised guideline on the environmental risk assessment of medicinal products for human use

Commentary on the draft revised guideline on the environmental risk assessment of medicinal products for human use

Abstract Applicants for marketing authorisation for human medicinal products in the European Union must submit an environmental risk assessment which is assessed by assessors from the national competent authorities. The EMA guideline on the environmental risk assessment of medicinal products for hum...

Full description

Bibliographic Details
Main Authors: Rhys Whomsley, Susanne Brendler-Schwaab, Eadaoin Griffin, John Jensen, Caroline Moermond, Birger Scholz, Laila Sortvik Nilssen, Henry Stemplewski, Ines Roennefahrt
Format: Article
Language:English
Published: SpringerOpen 2019-03-01
Series:Environmental Sciences Europe
Subjects:
Environmental risk assessment
European Medicines Agency
Human pharmaceuticals
ERA
EMA
CHMP
Online Access:http://link.springer.com/article/10.1186/s12302-019-0198-9

Internet

http://link.springer.com/article/10.1186/s12302-019-0198-9

Similar Items